Seaview Investment Managers’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Seaview Investment Managers’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13,877	Closed	-$1.25M	–	147
2024 Q4	$1.25M	Sell	13,877 -8,445	-38%	-$818K	0.35%	42
2024 Q3	$2.21M	Sell	22,322 -4,764	-18%	-$468K	0.66%	39
2024 Q2	$2.51M	Buy	27,086 +3,064	+13%	+$275K	0.76%	35
2024 Q1	$2.28M	Buy	+24,022	New	+$2.23M	0.69%	38
2021 Q3	–	Sell	-14,523	Closed	-$1.97M	–	127
2021 Q2	$1.97M	Buy	14,523 +4,367	+43%	+$574K	1%	31
2021 Q1	$1.38M	Buy	10,156 +6,725	+196%	+$1.01M	1.01%	31
2020 Q4	$483K	Sell	3,431 -705	-17%	-$90.3K	0.34%	54
2020 Q3	$467K	Buy	+4,136	New	+$464K	0.43%	38

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Seaview Investment Managers's XBI Position: Q1 2025 in Review

Seaview Investment Managers sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 13,877 shares — an estimated $1.25M sold.

Seaview Investment Managers first reported a position in XBI in Q3 2020 and held it in 8 quarters. The position peaked at $2.51M in Q2 2024. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Seaview Investment Managers reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Seaview Investment Managers sold 13,877 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $1.25M.
Seaview Investment Managers first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and held it in 8 quarters.
Seaview Investment Managers's State Street SPDR S&P Biotech ETF position peaked at $2.51M in Q2 2024.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Seaview Investment Managers's 13F filing for Q1 2025, filed 13 May 2025.